Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
... fully human, next generation monoclonal antibody that targets a unique epitope of the CD20 receptor on the surface of B-cells. Other anti-CD20 antibodies currently available or in development bind to a different epitope on the CD20 receptor. Ofatumumab is being developed under a co-development ...Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
... fully human, next generation monoclonal antibody that targets a unique epitope of the CD20 receptor on the surface of B-cells. This epitope is different than other anti-CD20 antibodies currently available or in ...CEL-SCI Corporation Reports 2009 Second Fiscal Quarter Financial Results
... of new biological and stem cell produced products. Promising preclinical studies supporting the Company's proprietary L.E.A.P.S.(TM) (Ligand epitope Antigen Presentation System) vaccine technology. The studies suggest that L.E.A.P.S. could potentially induce protection against illnesses such as ...Tracon Pharmaceuticals to Present Clinical Stage Programs at AACR 2009
... Date and Time: Wednesday, April 22, 2009, 8:00 AM Abstract Number: 5433 TRC093 Abstract Title: Targeting the HU177 cryptic collagen epitope with humanized antibody TRC093 functions cooperatively with anti-VEGF therapy to inhibit tumor growth Presenter: Jennifer M. Roth, PhD, Maine ...EpiVax Receives NIH Grant for $390,000 to Optimize HIV Vaccine Delivery
... as a stand-alone HIV antigen delivery system that obviates the dangers associated with non-specific activation of the immune system. epitope modification is an immunomodulatory approach EpiVax previously developed to reduce immunogenicity of protein therapeutics. Here, EpiVax ...CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
... and Dr. Dan Zimmerman, CEL-SCI's Senior Vice President of Research and Cellular Immunology, demonstrated that immunization with a LEAPS (Ligand epitope Antigen Presentation System) vaccine altered the immunological hormone (cytokine) balance toward a Th1 environment. It has been shown that a Th1 ...Gene Linked to Inflammatory Arthritis Also Raises Heart Risks
... of premature death from CVD in patients with inflammatory arthritis. The researchers said that, for RA patients in particular, having the shared epitope (SE) -- a group of HLA-DRB1 alleles with kindred amino acid traits -- plus anti-cyclic citrullinated peptide (anti-CCP) antibodies and being a ...Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
... research and development activities with its L.E.A.P.S.(TM) (Ligand epitope Antigen Presentation System) technology. L.E.A.P.S.(TM) is a novel T-cell ... peptides. The L.E.A.P.S.(TM) constructs containing the antigenic disease epitope linked to a T-cell binding ligand (TCBL) can be manufactured by peptide ...Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study
... fully human, next generation monoclonal antibody that targets a unique epitope of the CD20 molecule on the surface of B-cells. Other anti-CD20 antibodies currently available or in development bind to a different epitope on the CD20 molecule. Ofatumumab is being developed to treat CLL, ...Genmab Reaches Milestone in Ofatumumab Collaboration
... next generation monoclonal antibody that targets a distinct small loop epitope on the CD20 receptor on the surface of B-cells. This epitope is different from the other anti-CD20 antibodies currently available or in ...Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
... is a specialty biopharmaceutical company focused on the field of allergy. The company's range of allergy therapeutics utilizes its proprietary T-cell epitope desensitization technology, ToleroMune. Circassia's products offer potential major clinical benefits compared with existing therapies, and ...Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
... is a specialty biopharmaceutical company focused on the field of allergy. The company's range of allergy therapeutics utilizes its proprietary T-cell epitope desensitization technology, ToleroMune. Circassia's anti-allergy products offer potential major clinical benefits compared with existing therapies, ...NIH selects LIAI for major study on allergy molecular causes and possible treatments
... to scientists worldwide via the NIAIDs Immune epitope Database (IEDB), the worlds largest research ... bioinformatics along with the use of the allergy epitope information already in the IEDB. Bioinformatics ... advantage of that huge resource to improve our epitope identification algorithms based on that data, ...LIAI completes world's most comprehensive analysis on influenza virus data
... date worldwide, drawing from the NIAID's Immune epitope Database, a new worldwide scientific resource ... the first time that all known antibody and T cell epitope information has been compiled in one place," said ... but would have no way of knowing if a particular epitope had been used one time, for example by a single ...Touching Molecules With Your Bare Hands
... One region strongly associated with inhibiting epitope presentation to killer T cells corresponded to ... virus. These results indicate that avoiding epitope presentation during episome maintenance is key to ... will have to determine the responsible MHV-68 epitope and the mechanisms that engineer immune ....How A Latent Virus Eludes Immune Defenses
... One region strongly associated with inhibiting epitope presentation to killer T cells corresponded to ... virus. These results indicate that avoiding epitope presentation during episome maintenance is key to ... will have to determine the responsible MHV-68 epitope and the mechanisms that engineer immune ....New details on how the immune system recognizes influenza
... The analysis drew upon a much larger effort called the Immune epitope Database and Analysis Resources Program, which began in 2004 after NIAID ... and very little comes from humans or birds. In fact, only one antibody epitope came from a human. The LIAI researchers say more studies should be focused ...Fragment of yellow fever virus may hold key to safer vaccine
... all homed in on one particular part of the protein coating the virus. The epitope is called E-71, signifying its address on the envelope protein. Several ... against yellow fever likely span the pairs by grabbing the essential epitope on one and the supporting amino acids on the other, ter Meulen speculates. ...ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
... -Lead antibody targeting novel epitope of CD44 found in breast colon, and ... in animal models. ARIUS' program targets a novel epitope of CD44 that has been found in a number of cancer ... demonstrated that its antibody targets a novel epitope of CD44 that is present on the majority of human ...CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies
... that vaccines utilizing its proprietary L.E.A.P.S.(TM) (Ligand epitope Antigen Presentation System) vaccine technology could potentially induce ... peptides. The L.E.A.P.S. constructs containing the antigenic disease epitope linked to an Immune / T-cell binding ligand (I/TCBL) can be manufactured ...ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results
... - Expanding EHT 202 program to other CNS indications - Initiation of epitope discovery programs for ocular disorders with Allergan - ... a variety of ocular disease related models in order to discover novel epitope targets for the development of therapeutic antibodies. EHT/AGN ...Genmab Reaches Milestones in Ofatumumab Collaboration
... next generation monoclonal antibody that targets a distinct small loop epitope on the CD20 receptor on the surface of B-cells. This epitope is different to the other anti-CD20 antibodies currently available or in ...Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis
... fully human, next generation monoclonal antibody that targets a unique epitope of the CD20 receptor on the surface of B-cells. Other anti-CD20 antibodies currently available or in development bind to a different epitope on the CD20 receptor. Ofatumumab is being developed under a co-development ...Genmab Announces Update on Recruitment of Patients in ofatumumab CLL Pivotal Study
... fully human, next generation monoclonal antibody that targets a unique epitope of the CD20 receptor on the surface of b-cells. This epitope is different to the other anti-CD20 antibodies currently available or in ...Custom Epitope Peptide Microarray from LC Sciences
Description:... are available as part of our comprehensive epitope Peptide Microarray Service. Custom Probe ... Screen your samples against thousands of possible epitope sequences for discovery, or zero in on known ... experiment. One experiment using our high density epitope - peptide microarray is equivalent to 40 or more ...Epitope Peptide Microarray - Comprehensive Service from LC Sciences
Description:... LC Sciences provides a comprehensive epitope analysis service utilizing high density peptide ... Screen your samples against thousands of possible epitope sequences for discovery, or zero in on known ... tiling, and more. Thousands of customer specified epitope sequences can be synthesized on-chip and LC ...PT ModuleTM Deparaffinization and Heat-Induced Epitope Retrieval Solution (10X) from Lab Vision
Description:... enzymatic digestion for some markers while not for others. Non-enzymatic epitope unmasking techniques have been recently introduced to improve the immunoreactivity of many antigens in formaldehyde fixed tissues. Heat-Induced epitope Retrieval (HIER) in EDTA buffer has been found to improve the reactivity ...PT ModuleTM Deparaffinization and Heat-Induced Epitope Retrieval Solution (100X) from Lab Vision
Description:... enzymatic digestion for some markers while not for others. Non-enzymatic epitope unmasking techniques have been recently introduced to improve the immunoreactivity of many antigens in formaldehyde fixed tissues. Heat-Induced epitope Retrieval (HIER) in EDTA buffer has been found to improve the reactivity ...Rabbit Anti-QKI Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Description:... The epitope recognized by A300-183A maps to the C-terminus of isoform 5 of human quaking homolog according to entry AAH19917.1 (GeneID 9444). The epitope is not found in isoforms 1, 2, 3, 4, 6, 7 or 7B according to TrEMBL ...Rabbit Anti-Human PITPNB Polyclonal Antibody, Unconjugated from Atlas Antibodies
Description:... protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein epitope Signature Tag ....Rabbit Anti-Human SP2 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Description:... Transcription factor Sp2. [Source:Uniprot/SWISSPROT;Acc:Q02086] Antigen: Recombinant Protein epitope Signature Tag ....Rabbit Anti-Human C1QC Polyclonal Antibody, Unconjugated from Atlas Antibodies
Description:... Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein epitope Signature Tag ....Rabbit Anti-Human SYT16 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Description:... synaptotagmin XIV-like [Source:RefSeq_peptide;Acc:NP_114120] Antigen: Recombinant Protein epitope Signature Tag ....